HomeBBOT • NASDAQ
add
BridgeBio Oncology Therapeutics Inc
Previous close
$9.13
Day range
$8.80 - $9.29
Year range
$8.50 - $14.87
Market cap
727.50M USD
Avg Volume
263.74K
P/E ratio
45.54
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 43.41M | 98.40% |
Net income | -38.80M | -97.07% |
Net profit margin | — | — |
Earnings per share | -0.49 | — |
EBITDA | -43.32M | -98.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 425.46M | 173.38% |
Total assets | 448.38M | 172.90% |
Total liabilities | 37.28M | 90.42% |
Total equity | 411.10M | — |
Shares outstanding | 80.03M | — |
Price to book | 1.78 | — |
Return on assets | -23.26% | — |
Return on capital | -25.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -38.80M | -97.07% |
Cash from operations | -42.23M | -180.90% |
Cash from investing | 7.77M | -69.61% |
Cash from financing | -586.00K | -1,226.92% |
Net change in cash | -35.05M | -431.54% |
Free cash flow | -23.96M | — |
About
Founded
2016
Headquarters
Website
Employees
92
